Evaluation of the efficacy of sarolaner (Simparica®) in the prevention of babesiosis in dogs

BACKGROUND: Canine babesiosis is a clinically significant emerging vector-borne disease caused among others by the protozoan Babesia canis. The efficacy of sarolaner (Simparica®; Zoetis; at the minimum recommended label dose of 2.0 mg per kg bodyweight) in the prevention of babesiosis was evaluated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Parasit Vectors
Main Authors: Geurden, Thomas, Six, Robert, Becskei, Csilla, Maeder, Steven, Lloyd, Anne, Mahabir, Sean, Fourie, Josephus, Liebenberg, Julian
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5588728/
https://ncbi.nlm.nih.gov/pubmed/28877743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13071-017-2358-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados